Digital Health mobile apps and connected medical devices are rapidly changing how patients learn, monitor, diagnose and treat disease. Even in these early days of the digital transformation of healthcare, connected medical devices and digital services are winning reimbursement as “digiceuticals” by payors and insurers. However, the critical need going forward is how to measure, compare and prove these new tools and digital biomarkers are safe, effective and valuable at scale, not just in the USA but globally, across geographies, cultures and health systems.
Day 2 Welcomes & Opening Remarks
Eugene Fitzgerald Professor of Materials Science & Engineering
Jeffrey Grossman Professor of Materials Science & Engineering
Single-cell mass as a clinical tool for guiding treatment decisions
Keith Ligon Associate Professor of Pathology at Harvard Medical School Scott Manalis Andrew and Erna Viterbi Professor of Biological Engineering Clifford Reid CEO of Travera
Contact
Polina Golland will discuss her group's research in computational analysis of MRI scans that aims to provide accurate measurements of healthy anatomy and physiology, and biomarkers of pathology. Applications range from fetal development to aging brain.